Pacer Advisors
IMVT icon

Pacer Advisors’s Immunovant IMVT Stock Holding History

Pacer Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Buy
+1,193
New +$36.3K ﹤0.01% 2056
2024
Q3 		– Sell
-800
Closed -$21.1K – 2619
2024
Q2 		$21.1K Sell
800
-543
-40% -$15.4K ﹤0.01% 3420
2024
Q1 		$43.4K Buy
+1,343
New +$49K ﹤0.01% 3228
2021
Q2 		– Sell
-4,594
Closed -$74K – 1473
2021
Q1 		$74K Buy
4,594
+2,184
+91% +$57.6K ﹤0.01% 1350
2020
Q4 		$111K Buy
+2,410
New +$111K ﹤0.01% 1350

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pacer Advisors's IMVT Position: Q2 2026 in Review

Pacer Advisors opened a new position in Immunovant (IMVT) in Q2 2026: 1,193 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #2056 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in IMVT as recently as Q2 2024.

Pacer Advisors first reported a position in IMVT in Q4 2020 and has held it in 5 quarters since. The position peaked at $111K in Q4 2020. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Pacer Advisors held 1,193 shares of Immunovant worth $46K as of Q2 2026.
  • Immunovant was a new Pacer Advisors position in Q2 2026.
  • Immunovant made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2056 holding.
  • Pacer Advisors first reported a position in Immunovant in Q4 2020 and has held it in 5 quarters since.
  • Pacer Advisors's Immunovant position peaked at $111K in Q4 2020.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.